Trials / Completed
CompletedNCT00698152
A Clinical Investigation of ArComXL® Polyethylene in Total Hip Replacement
A Prospective, Non-controlled, Clinical Investigation of ArComXL® Polyethylene in Total Hip Replacement
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 149 (actual)
- Sponsor
- Zimmer Biomet · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this data collection is to determine long term survival rate of ArComXL® highly cross-linked polyethylene
Detailed description
Approximately 500 patients (cases) will be enrolled in this data collection effort and 10-year follow-up will be attempted. Follow-up will be obtained by sending a questionnaire directly to the patients by mail. The follow-up will be annually and only survivorship data will be collected. This data collection project was developed in order to determine the actual long-term (10-year) survival rate of Biomet's ArCom XL highly cross-linked polyethylene. Data will be collated for uncemented cases only. This will eliminate the possibility of cement or cement debris being a confounding variable. The data gathered will be collated and used to provide feedback to designing engineers, support marketing efforts, and answer potential questions from reimbursement agencies.
Conditions
Timeline
- Start date
- 2006-01-23
- Primary completion
- 2016-01-15
- Completion
- 2016-01-15
- First posted
- 2008-06-17
- Last updated
- 2020-03-30
Locations
5 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00698152. Inclusion in this directory is not an endorsement.